​Main conclusions of the January-December 2025 results

• Record annual figures in revenue, EBITDA and net profit

• Revenue totalled €1,252.0 million in 2025, an increase of 4.0% compared to the previous year. and of 6.1% on a like-for-like basis, driven by strong volume growth.

• €290.0 million of EBITDA in 2025, a growth of 1.6% compared to 2024, and of 6.2% on a like-for-like basis.

• In 2025, the reported EBITDA margin was 23.2% (-0.5 p.p. vs. 2024), impacted by currency fluctuations and collagen hides inflation in Europe. On a like-for-like basis, the 2025 EBITDA margin remains stable at 23.7% compared to the previous year.

• Net profit of €159.9 million in 2025, 1.8% higher than the previous year.

• Net bank debt as of December 2025 stands at €206.1 million, higher than the €146.9 million of December 2024 due to the increase in shareholder remuneration and share buybacks.

• An estimated shareholder remuneration of €3.25 per share, charged to the 2025 results, is proposed for approval by the Shareholders' Meeting, of which €2.25 is ordinary and €1.00 is extraordinary.

• According to José Antonio Canales, CEO of the Viscofan Group:

“We have completed the Beyond’25 strategic plan, consolidating a new purpose that has allowed us to reinforce our traditional leadership in casings and to explore new businesses as future growth drivers. In fact, we finished fiscal year 2025 with record highs in key financial figures, even in an adverse environment of currencies and raw materials. The commitment of Viscofan’s 5,900 employees and the strength of our business model are key pillars in achieving these record highs in financial results and shareholder returns.”

From this prominent position, we are unveiling the Beat'30 strategy, an inspiring and compelling plan with which we expect to achieve historic rates of growth, profitability and sustainable value creation.”

For more information, please see RESULTS REPORT​